Take Action: Tell your senators to reject harmful cuts to health care!
Last week, the Food and Drug Administration (FDA) finalized a rule that will permit people with Medicare, and others, to purchase hearing aids online or in stores, at lower costs, and without a prescription. The long-awaited rule, which will go into effect in October, may make hearing aids more affordable […]
The Inflation Reduction Act (IRA), signed into law by President Biden last week, includes immediate and longer-term policies that change what people with Medicare will pay for their prescription drugs. These reforms include establishing a hard cap on prescription drug costs for people with Medicare, simplifying and expanding access to […]
The Medicare Rights Center thanks President Biden for signing—and the House and Senate for passing—the Inflation Reduction Act (IRA) of 2022. This landmark legislation includes policies we have long championed to make health care and prescription drugs more affordable. Thanks to the IRA: More low-income Medicare beneficiaries will be able […]
Passed by the Senate on Sunday, the Inflation Reduction Act of 2022 (IRA) includes many long-sought changes to make health care and prescription drugs more affordable for current and future Medicare beneficiaries. This bill would transform Medicare’s drug pricing system by allowing Medicare to negotiate drug prices for the first […]
A recent study by the polling firm Gallup and the nonprofit West Health, which focuses on lowering health care costs for older adults, found that nearly 40% of American adults in the past six months have struggled to afford health care, including prescription drugs. They have borrowed money, cut back […]
As recently outlined, the Inflation Reduction Act of 2022 incorporates many of Medicare Rights’ long-standing recommendations to meaningfully improve the lives of people with Medicare and their families. It would make transformational, long overdue changes to Medicare’s drug pricing system by allowing Medicare to negotiate drug prices for the first […]
